{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:18:13Z","timestamp":1772165893417,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bronchoalveolar lavage (BAL) is a major diagnostic tool in interstitial lung disease (ILD). Its use remains largely quantitative, usually focused on cell differential ratio. However, cellular morphological features provide additional valuable information. The significance of the \u201cimmune alveolitis\u201d cytological profile, characterized by lymphocytic alveolitis with activated lymphocytes and macrophages in epithelioid transformation or foamy macrophages desquamating in cohesive clusters with lymphocytes, remains unknown in ILD. Our objective was to describe patients\u2019 characteristics and diagnoses associated with an immune alveolitis profile in undiagnosed ILD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a monocentric retrospective observational study. Eligible patients were adults undergoing diagnostic exploration for ILD and whose BAL fluid displayed an immune alveolitis profile. For each patient, we collected clinical, radiological and biological findings as well as the final etiology of ILD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Between January 2012 and December 2018, 249 patients were included. Mean age was 57\u2009\u00b1\u200916\u00a0years, 140 patients (56%) were men, and 65% of patients were immunocompromised. The main etiological diagnosis was\n                      <jats:italic>Pneumocystis<\/jats:italic>\n                      pneumonia (PCP) (24%), followed by drug-induced lung disease (DILD) (20%), viral pneumonia (14%) and hypersensitivity pneumonitis (HP) (10%). All PCP were diagnosed in immunocompromised patients while HP was found in only 8% of this subgroup. DILD and viral pneumonia were also commonly diagnosed in immunocompromised patients (94% and 80%, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study highlights the additional value of BAL qualitative description in ILD. We suggest incorporating the immune alveolitis profile for the diagnosis and management of ILD, especially in immunocompromised patients, since it guides towards specific diagnoses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-022-01871-w","type":"journal-article","created":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T06:02:40Z","timestamp":1646460160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0638-7619","authenticated-orcid":false,"given":"Antoine","family":"Moui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Dirou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Sagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renan","family":"Liberge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Defrance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Paul","family":"Arrigoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Morla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Kandel-Aznar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Cellerin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Cavailles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Eschapasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florent","family":"Morio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Antoine","family":"Gourraud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Goronflot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrien","family":"Tissot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois-Xavier","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,5]]},"reference":[{"issue":"2","key":"1871_CR1","doi-asserted-by":"publisher","first-page":"1602419","DOI":"10.1183\/13993003.02419-2016","volume":"50","author":"B Duchemann","year":"2017","unstructured":"Duchemann B, Annesi-Maesano I, Jacobe de Naurois C, Sanyal S, Brillet P-Y, Brauner M, et al. Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris. Eur Respir J. 2017;50(2):1602419.","journal-title":"Eur Respir J"},{"key":"1871_CR2","doi-asserted-by":"crossref","unstructured":"American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias: This Joint Statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS Board of Directors, June 2001 and by The ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165(2):277\u2013304.","DOI":"10.1164\/ajrccm.165.2.ats01"},{"issue":"6","key":"1871_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, et al. An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733\u201348.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1871_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/1744666X.2018.1411190","volume":"14","author":"F Atzeni","year":"2018","unstructured":"Atzeni F, Gerardi MC, Barilaro G, Masala IF, Benucci M, Sarzi-Puttini P. Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review. Expert Rev Clin Immunol. 2018;14(1):69\u201382.","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"1871_CR5","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.rmed.2009.02.009","volume":"103","author":"S Mittoo","year":"2009","unstructured":"Mittoo S, Gelber AC, Christopher-Stine L, Horton MR, Lechtzin N, Danoff SK. Ascertainment of collagen vascular disease in patients presenting with interstitial lung disease. Respir Med. 2009;103(8):1152\u20138.","journal-title":"Respir Med"},{"issue":"8","key":"1871_CR6","first-page":"1264","volume":"56","author":"CV Cotton","year":"2016","unstructured":"Cotton CV, Spencer LG, New RP, Cooper RG. The utility of comprehensive autoantibody testing to differentiate connective tissue disease associated and idiopathic interstitial lung disease subgroup cases. Rheumatology. 2016;56(8):1264\u201371.","journal-title":"Rheumatology"},{"issue":"2","key":"1871_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S2213-2600(17)30433-2","volume":"6","author":"DA Lynch","year":"2018","unstructured":"Lynch DA, Sverzellati N, Travis WD, Brown KK, Colby TV, Galvin JR, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society white paper. Lancet Respir Med. 2018;6(2):138\u201353.","journal-title":"Lancet Respir Med"},{"issue":"5","key":"1871_CR8","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198(5):e44-68.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1871_CR9","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0033-8389(05)70334-1","volume":"39","author":"J Collins","year":"2001","unstructured":"Collins J. CT signs and patterns of lung disease. Radiol Clin North Am. 2001;39(6):1115\u201335.","journal-title":"Radiol Clin North Am"},{"issue":"9","key":"1871_CR10","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","volume":"185","author":"KC Meyer","year":"2012","unstructured":"Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185(9):1004\u201314.","journal-title":"Am J Respir Crit Care Med"},{"issue":"117","key":"1871_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1183\/09059180.00005510","volume":"19","author":"AU Wells","year":"2010","unstructured":"Wells AU. The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease. Eur Respir Rev. 2010;19(117):237\u201341.","journal-title":"Eur Respir Rev"},{"issue":"2","key":"1871_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/MD.0b013e31816d1dda","volume":"87","author":"F Morell","year":"2008","unstructured":"Morell F, Roger A, Reyes L, Cruz MJ, Murio C, Mu\u00f1oz X. Bird fancier\u2019s lung: a series of 86 patients. Medicine (Baltimore). 2008;87(2):110\u201330.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"1871_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2213-2600(18)30064-X","volume":"6","author":"P Spagnolo","year":"2018","unstructured":"Spagnolo P, Rossi G, Trisolini R, Sverzellati N, Baughman RP, Wells AU. Pulmonary sarcoidosis. Lancet Respir Med. 2018;6(5):389\u2013402.","journal-title":"Lancet Respir Med"},{"issue":"5","key":"1871_CR14","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1016\/j.annpat.2009.07.043","volume":"29","author":"C Sagan","year":"2009","unstructured":"Sagan C, B\u00e9gueret H. Cas pratiques: du lavage broncho-alv\u00e9olaire \u00e0 la biopsie pulmonaire. Ann Pathol. 2009;29(5):S103\u20134.","journal-title":"Ann Pathol"},{"issue":"5","key":"1871_CR15","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1055\/s-2007-991523","volume":"28","author":"C Cordeiro","year":"2007","unstructured":"Cordeiro C, Jones J, Alfaro T, Ferreira A. Bronchoalveolar lavage in occupational lung diseases. Semin Respir Crit Care Med. 2007;28(5):504\u201313.","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"1871_CR16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09031936.93.01010005","volume":"1","author":"U Costabel","year":"1988","unstructured":"Costabel U. The alveolitis of hypersensitivity pneumonitis. Eur Respir J. 1988;1(1):5\u20139.","journal-title":"Eur Respir J"},{"issue":"10","key":"1871_CR17","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1183\/09031936.93.03101128","volume":"3","author":"DA Hughes","year":"1990","unstructured":"Hughes DA, Haslam PL. Effect of smoking on the lipid composition of lung lining fluid and relationship between immunostimulatory lipids, inflammatory cells and foamy macrophages in extrinsic allergic alveolitis. Eur Respir J. 1990;3(10):1128\u201339.","journal-title":"Eur Respir J"},{"issue":"11","key":"1871_CR18","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.2169\/internalmedicine.53.0520","volume":"53","author":"K Tamai","year":"2014","unstructured":"Tamai K, Tachikawa R, Tomii K, Nagata K, Otsuka K, Nakagawa A, et al. Prognostic value of bronchoalveolar lavage in patients with non-HIV pneumocystis pneumonia. Intern Med. 2014;53(11):1113\u20137.","journal-title":"Intern Med"},{"issue":"2","key":"1871_CR19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3343\/alm.2015.35.2.220","volume":"35","author":"W Lee","year":"2015","unstructured":"Lee W, Chung WS, Hong K-S, Huh J. Clinical usefulness of bronchoalveolar lavage cellular analysis and lymphocyte subsets in diffuse interstitial lung diseases. Ann Lab Med. 2015;35(2):220\u20135.","journal-title":"Ann Lab Med"},{"issue":"1","key":"1871_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13613-019-0604-x","volume":"9","author":"BJ Gaborit","year":"2019","unstructured":"Gaborit BJ, Tessoulin B, Lavergne R-A, Morio F, Sagan C, Canet E, et al. Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study. Ann Intensive Care. 2019;9(1):131.","journal-title":"Ann Intensive Care"},{"issue":"3","key":"1871_CR21","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","volume":"202","author":"G Raghu","year":"2020","unstructured":"Raghu G, Remy-Jardin M, Ryerson CJ, Myers JL, Kreuter M, Vasakova M, et al. Diagnosis of hypersensitivity pneumonitis in adults. An official ATS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2020;202(3):e36-69.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"1871_CR22","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1164\/rccm.201710-1986OC","volume":"197","author":"J Morisset","year":"2018","unstructured":"Morisset J, Johannson KA, Jones KD, Wolters PJ, Collard HR, Walsh SLF, et al. Identification of diagnostic criteria for chronic hypersensitivity pneumonitis. An international modified Delphi survey. Am J Respir Crit Care Med. 2018;197(8):1036\u201344.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1871_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0272-5231(03)00143-6","volume":"25","author":"U Costabel","year":"2004","unstructured":"Costabel U, Uzaslan E, Guzman J. Bronchoalveolar lavage in drug-induced lung disease. Clin Chest Med. 2004;25(1):25\u201335.","journal-title":"Clin Chest Med"},{"issue":"4","key":"1871_CR24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/PAS.0b013e318243fd9a","volume":"36","author":"BT Larsen","year":"2012","unstructured":"Larsen BT, Vaszar LT, Colby TV, Tazelaar HD. Lymphoid hyperplasia and eosinophilic pneumonia as histologic manifestations of amiodarone-induced lung toxicity. Am J Surg Pathol. 2012;36(4):509\u201316.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"1871_CR25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1055\/s-2007-991521","volume":"28","author":"M Drent","year":"2007","unstructured":"Drent M, Mansour K, Linssen C. Bronchoalveolar lavage in sarcoidosis. Semin Respir Crit Care Med. 2007;28(5):486\u201395.","journal-title":"Semin Respir Crit Care Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-01871-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-022-01871-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-01871-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T07:39:40Z","timestamp":1674891580000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-022-01871-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,5]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1871"],"URL":"https:\/\/doi.org\/10.1186\/s12890-022-01871-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-594950\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-594950\/v2","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,5]]},"assertion":[{"value":"13 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We received ethics approval from the \u00abD\u00e9l\u00e9gation \u00e0 la recherche clinique et \u00e0 l\u2019innovation (DRCI)\u00bb of the University Hospital of Nantes, and from the \u00abInstitutional Review Board of the French-speaking Respiratory Medicine Society (Soci\u00e9t\u00e9 de Pneumologie de Langue Fran\u00e7aise, SPLF)\u00bb. Written informed consent was not required for this work because it consists of retrospective data. All patients received a written information letter and did not express their opposition.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}